Macrovascular outcomes and mortality after bariatric surgery in patients with metabolic dysfunction–associated steatotic liver disease, and Type 2 diabetes
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease globally, with a significant association between MASLD and Type 2 diabetes mellitus (T2DM), obesity, and cardiovascular disease (CVD). While bariatric surgery (BS) has sho...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2025-06-01
|
| シリーズ: | Diabetology & Metabolic Syndrome |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s13098-025-01767-9 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
